Jpmorgan Funds - Fundsupermart.com

JPMorgan Funds - Global Life Sciences Fund
Schedule of Investments (Market Value Expressed in USD)
As at 30 June 2008
Quantity/
Nominal
Value
Name of Securities
Market
Value
% of
Net
Assets
Transferable Securities Admitted to an Official Exchange Listing
ITALY
13,866 DiaSorin 288,376 0.91
Shares
7,981 Newron Pharmaceuticals 246,981 0.78
UNITED STATES OFAMERICA
27,000 Abbott Laboratories 1,432,890 4.52
535,357 1.69
19,200 Aetna 777,024 2.45 IRELAND
8,320 Alexion Pharmaceuticals 606,362 1.91 12,883 Elan ADR 454,770 1.43
100,100 Barrier Therapeutics 403,403 1.27
14,100 BioMarin Pharmaceuticals 420,462 1.33
454,770 1.43
282,300 Bionovo
33,400 Bristol-Myers Squibb
21,200 Celgene
321,822
685,368
1,352,348
1.01
2.16
4.26
SWEDEN
20,046 Elekta - B Shares 387,730 1.22
93,900 Combinatorx
7,100 CR Bard
329,965
629,628
1.04
1.98
387,730 1.22
20,900 CVS Caremark 832,865 2.62 DENMARK
40,510 Cypress Bioscience 289,241 0.91 5,987 Genmab 228,637 0.72
98,900 Cytokinetics 382,743 1.21
271,288 Dusa Pharmaceuticals 549,358 1.73
228,637 0.72
22,900 Gilead Sciences 1,209,120 3.81
16,000 Hologic 349,442 1.10
Total Shares 30,412,264 95.84
6,900 Illumina
36,600 Incyte
291,100 Lev Pharmaceuticals
613,548
277,428
538,535
1.93
0.87
1.70
Total Transferable Securities Admitted to an
Official Exchange Listing
30,412,264 95.84
23,916 Medivation
32,300 Merck & Co.
300,385
1,214,803
0.95
3.83
Total Investments 30,412,264 95.84
165,700 Protalix BioTherapeutics
23,900 Rigel Pharmaceuticals
490,472
577,902
1.55
1.82
Cash 721,126 2.27
63,400 Schering-Plough
50,500 Seattle Genetics
1,235,666
440,360
3.89
1.39
Other Assets/(Liabilities) 598,785 1.89
122,000 Synergetics USA330,010
28,000 Thoratec 490,840
1.04
1.55
Total Net Assets 31,732,175 100.00
184,200 ULURU 156,570 0.50
5,680 United Therapeutics 549,739 1.73
13,700 VCAAntech
12,000 Xenoport
8,600 Zimmer Holdings
385,655
480,600
584,972
1.22
1.51
1.84
Allocation of Portfolio as at 30 June 2008
Shares
% of
Net Assets
UNITED KINGDOM
47,125 Hikma Pharmaceuticals
538,359 Oxford Biomedica
27,305 SSL International
19,239,526
469,919
246,946
243,417
60.63
1.47
0.78
0.77
Health Care
Materials
Consumer Staples
Total Shares
Cash and Other Assets/(Liabilities)
89.29
3.93
2.62
95.84
4.16
19,883 Synergy Healthcare 291,454 0.92 Total 100.00
1,251,736 3.94
GERMANY
14,885 Bayer 1,245,087 3.93
21,588 Wilex 248,673 0.78
1,493,760 4.71
AUSTRIA
28,783 Intercell 1,417,046 4.47
1,417,046 4.47
SWITZERLAND
970 Galenica Holding Registered Shares 349,015 1.10
9,324 Novartis Registered Shares 513,878 1.62
3,054 Roche Holding - Genussschein 545,154 1.72
1,408,047 4.44
JAPAN
50,400 Chugai Pharmaceutical 809,621 2.55
12,600 Suzuken 466,998 1.47
1,276,619 4.02
JERSEY
61,106 Shire 1,004,791 3.17
1,004,791 3.17
ISRAEL
20,200 Teva Pharmaceutical Industries ADR 917,787 2.89
917,787 2.89
FRANCE
8,943 Sanofi-Aventis 594,381 1.87
10,336 Transgene 202,077 0.64
796,458 2.51
81
Quantity/
Nominal
Value
Name of Securities
Market
Value
% of
Net
Assets
Allocation of Portfolio as at 31 December 2007 (Unaudited)
Shares
% of
Net Assets
Health Care 94.36
Materials 2.50
Total Shares 96.86
Cash and Other Assets/(Liabilities) 3.14
Total 100.00